12:00 AM
 | 
Apr 04, 2011
 |  BC Week In Review  |  Company News  |  Other News

Generex drug delivery news

Generex said it plans to spin out its wholly-owned subsidiary, Antigen Express Inc. and its immunotherapeutic vaccines, including the Ii-Key/HER2/neu cancer vaccine ( AE37), which...

Read the full 127 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >